Piretanide is a loop diuretic used to treat conditions such as edema associated with congestive heart failure, liver disease, and renal disorders, as well as hypertension. It was developed as a potent diuretic agent in the loop diuretic class and introduced for clinical use in the 1970s. Its history is associated with its effectiveness in promoting rapid diuresis and reducing fluid overload in patients with cardiovascular and renal conditions. Piretanide works by inhibiting sodium and chloride reabsorption in the thick ascending limb of the loop of Henle in the kidneys, leading to increased excretion of water, sodium, potassium, and chloride, which helps reduce fluid retention and lower blood pressure.
BRAND NAMES
Arelix: Widely recognized brand, often used in tablet form (e.g., 6mg).
Eurelix: Known brand name for this loop diuretic.
Tauliz: Another common trade name.
Arlix/Diumax: Additional synonyms listed.
MECHANISM OF ACTION
Piretanide is a loop diuretic that works by inhibiting the Na⁺/K⁺/2Cl⁻ co-transporter in the thick ascending limb of the loop of Henle in the kidney. This blocks the reabsorption of sodium and chloride, leading to increased excretion of water along with electrolytes such as potassium and calcium. The result is a strong diuretic effect that reduces fluid overload and lowers blood pressure.
PHARMACOKINETICS
Absorption
Piretanide is well absorbed from the gastrointestinal tract after oral administration, with relatively rapid onset of action. Peak plasma concentrations are typically reached within 1–2 hours. Its bioavailability is moderate and may vary among individuals, but food has little significant effect on overall absorption.
Distribution
Piretanide is moderately bound to plasma proteins and is distributed mainly within the extracellular fluid. It has a relatively small volume of distribution and does not extensively accumulate in tissues. It does not readily cross the blood–brain barrier and acts primarily at the renal tubules where it exerts its diuretic effect.
Metabolism
Piretanide undergoes minimal hepatic metabolism, with most of the drug remaining unchanged in the body. A small portion may be metabolized in the liver, but this pathway is not significant for its elimination or activity. Its pharmacological effect is mainly due to the unchanged drug acting on the kidneys.
Elimination
Piretanide is eliminated mainly through the kidneys, with most of the drug excreted unchanged in the urine via glomerular filtration and tubular secretion. It has a relatively short elimination half-life, which supports once or twice daily dosing depending on the clinical condition. A small amount may be excreted in bile.
PHARMACODYNAMICS
Piretanide is a loop diuretic that produces a strong diuretic and antihypertensive effect by inhibiting the Na⁺/K⁺/2Cl⁻ co-transport system in the thick ascending limb of the loop of Henle. This blocks the reabsorption of sodium and chloride, leading to increased excretion of water along with electrolytes such as potassium, calcium, and magnesium.
ADMINISTRATION
Piretanide is administered orally in tablet form or by intravenous injection in hospital settings when rapid diuresis is required. Oral administration is usually preferred for chronic conditions such as edema and hypertension, while IV use is reserved for acute fluid overload. It is typically given in the morning to avoid nocturnal urination.
DOSAGE AND STRENGTH
Piretanide is usually given in adults at an oral dose of 3–6 mg once daily, which may be increased to 12 mg/day in severe edema or resistant cases, depending on clinical response. In acute settings, parenteral dosing may be used under medical supervision. It is available in tablet strengths of 3 mg and 6 mg, allowing flexible dose adjustment based on patient needs.
DRUG INTERACTIONS
Piretanide may interact with other antihypertensive drugs, leading to additive blood pressure–lowering effects and possible hypotension. When used with aminoglycoside antibiotics or other ototoxic drugs, there is an increased risk of hearing damage. Concurrent use with NSAIDs may reduce its diuretic and antihypertensive effectiveness.
FOOD INTERACTIONS
Piretanide has no significant food interactions, and its absorption is not affected much by food. It may be taken with or without food, but taking it with food can help reduce stomach irritation. It is usually given in the morning to avoid night-time urination.
CONTRAINDICATIONS
Piretanide is contraindicated in patients with known hypersensitivity to the drug or other loop diuretics. It should not be used in cases of severe electrolyte imbalance (such as marked hypokalemia, hyponatremia, or hypovolemia) or anuria where urine production is absent. It is also contraindicated in severe renal failure unresponsive to diuretics. Caution is required in patients with gout due to the risk of hyperuricemia.
SIDE EFFECTS
Hypokalemia
Hyponatremia
Dehydration
Hypotension
Dizziness
Headache
Polyuria
OVER DOSAGE
Piretanide overdose can cause excessive diuresis leading to severe dehydration, electrolyte imbalances such as hypokalemia and hyponatremia, and hypotension. Patients may experience dizziness, weakness, muscle cramps, and in severe cases, circulatory collapse.
TOXICITY
Piretanide toxicity is mainly due to excessive diuresis, leading to severe dehydration, electrolyte disturbances (especially hypokalemia, hyponatremia), and hypotension. In severe cases, it may cause arrhythmias, muscle weakness, confusion, or circulatory collapse. Ototoxicity is rare but can occur at high doses or with rapid IV administration. Treatment is supportive with fluid and electrolyte correction.
